Abstract:Background: The effects of anesthetic drugs on myocardial cells have been a subject of research for the last 50 years. The clinical benefits of halogenated agents, particularly sevoflurane, have been demonstrated in cardiac surgery patients. These benefits are due to the action of different enzymes and a variety of molecular pathways mediated by the action of small noncoding RNAs (sRNA) such as microRNAs (miRNAs). However, the modulation potential induced by anesthetic drugs on the miRNA expression and their cardioprotective effects is unknown. Objective: To analyze the variation in the expression of a panel of miRNAs induced by halogenated agents to identify their cardioprotective effects. Aims: Variations in the expression of specific miRNAs induce the potential cardioprotective effects of halogenated agents. Methods: An ischemia/reperfusion (I/R) in vitro model of primary human cardiac myocytes (HCMs) was performed. Four study groups were performed: control group (standard culture conditions), I/R group (without hypnotic drugs exposition), I/R-propofol group (I/R-P), and I/R-sevoflurane group (I/R-S). The secretion of p53 and Akt1 cytokines was quantified in the different cell study groups using an Enzyme-Linked ImmunoSorbent Assay, and the differentially expressed miRNAs were identified carrying out a complete genomic sequencing using the Next Generation Sequencing (NGS). Results: HCMs subjected to the I/R procedure and exposed to sevoflurane showed lower secretion levels of p53 factor and higher levels of Akt-1 cytokine compared to HCMs exposed to propofol (p53: I/R-S: 10.43 ± 0.91 ng/mL; I/R-P: 137.92 ± 7.53 ng/mL; p > 0.05); (Akt1: I/R-S: 0.62 ± 0.12 ng/mL; I/R-P: 0.23 ± 0.05 ng/mL; p > 0.05). The miRNA gene expression analysis (NGS) showed significantly increased expression of the hsa-miR-140-5p and hsa-miR-455-5p, both miRNAs associated with cardiac function; the hsa-miR-98-5p and hsa-miR-193a-5p, both related to apoptosis inhibition; and the hsa-let-7d-5p associated with myocardial protection. This increase was observed in the HCMs group exposed to sevoflurane in comparison to the propofol group. Conclusions: Sevoflurane-induced miRNAs overexpression confers cardioprotection through various mechanisms at the DNA level and the different signaling pathways levels, such as Akt/ERK.

miRNA Expression: I/R Cardiomyocyte and Sevoflurane

[Sevoflurane Postconditioning Attenuates Myocardial Apoptosis in Isolated Rat Hearts Via a Modulation of Bcl-2 Family Proteins].

MicroRNA-325-3p prevents sevoflurane-induced learning and memory impairment by inhibiting Nupr1 and C/EBP/IGFBP5 signaling in rats

Circulating microRNAs indicate cardioprotection by sevoflurane inhalation in patients undergoing off-pump coronary artery bypass surgery.

Up-regulation of Microrna-21 Mediates Isoflurane-Induced Protection of Cardiomyocytes.

The SNHG10-miR-495-3p-PTEN axis is involved in sevoflurane-mediated protective effects in cardiomyocytes against hypoxia/reoxygenation injury

Inhibition of miR-495-3p ameliorated sevoflurane induced damage through BDNF/ERK/CREB signaling pathways in HT22 cells

Postconditioning of Sevoflurane and Propofol is Associated with Mitochondrial Permeability Transition Pore

Progression in the study of protective effect of microRNAs against sevoflurane-induced postoperative cognitive dysfunction and potential mechanisms

Sevoflurane Postconditioning Reduces Myocardial Reperfusion Injury in Rat Isolated Hearts Via Activation of PI3K/Akt Signaling and Modulation of Bcl-2 Family Proteins.

MiR-34a-5p mediates sevoflurane preconditioning induced inhibition of hypoxia/reoxygenation injury through STX1A in cardiomyocytes.

RETRACTED: Inhibition of Mir-495-3p Ameliorated Sevoflurane Induced Damage Through BDNF/ERK/CREB Signaling Pathways in HT22 Cells

Sevoflurane preconditioning attenuates myocardial cell damage caused by hypoxia and reoxygenation via regulating the NORAD/miR-144-3p axis

Role of microRNA‐145 in protection against myocardial ischemia/reperfusion injury in mice by regulating expression of GZMK with the treatment of sevoflurane

Sevoflurane up-regulates microRNA-204 to ameliorate myocardial ischemia/reperfusion injury in mice by suppressing Cotl1

Hypercholesterolemia Blocked Sevoflurane-Induced Cardioprotection Against Ischemia–reperfusion Injury by Alteration of the MG53/RISK/GSK3β Signaling

Altered Hippocampal Microrna Expression Profiles in Neonatal Rats Caused by Sevoflurane Anesthesia: MicroRNA Profiling and Bioinformatics Target Analysis

Sevoflurane attenuates cardiomyocyte apoptosis by mediating the miR-219a/AIM2/TLR4/MyD88 axis in myocardial ischemia/reperfusion injury in mice

Sevoflurane exerts protection against myocardial ischemia-reperfusion injury and pyroptosis through the circular RNA PAN3/microRNA-29b-3p/stromal cell-derived factor 4 axis

The Role Of Microrna In Anesthetic-Induced Cardiac Preconditioning

MicroRNA-27a-3p Suppression of Peroxisome Proliferator-Activated Receptor-Γ Contributes to Cognitive Impairments Resulting from Sevoflurane Treatment.